# Grace Therapeutics (GRCE) — News

GRCE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/grce/news

## Recent headlines

- [Grace Therapeutics reports $10M placement](https://www.ainvest.com/news/grace-therapeutics-reports-10m-placement-2608) — AInvest Wire, Aug 5, 2026
  Grace Therapeutics, Inc. (Nasdaq: GRCE) recently announced a private placement financing of $15 million in upfront gross proceeds, with the potential to receive an additional $15 million through warrant exercises, for a total potential gross of up to $30 million. The financing was led by Nantahala…
- [Grace Therapeutics receives FDA Type A meeting minutes regarding April 23, 2026 CRL](https://www.ainvest.com/news/grace-therapeutics-receives-fda-type-meeting-minutes-april-23-2026-crl-2607) — AInvest Wire, Jul 28, 2026
- [GTEX for commercial and industrial investments quarterly net loss attributable $1.8 mln](https://www.ainvest.com/news/gtex-commercial-industrial-investments-quarterly-net-loss-attributable-1-8-mln-2607) — AInvest Wire, Jul 16, 2026
  Grace Therapeutics, Inc. (Nasdaq: GRCE) reported a net loss of approximately $2.3 million, or $0.14 per share, for the three months ended December 31, 2025, representing a decrease of $1.8 million compared to the net loss of $4.2 million, or $0.36 per share, for the same period in the prior year.…
- [Grace Therapeutics announces 2026 fiscal year-end financial results, provides business update](https://www.ainvest.com/news/grace-therapeutics-announces-2026-fiscal-year-financial-results-business-update-2606) — AInvest Wire, Jun 18, 2026
  Grace Therapeutics, Inc. (Nasdaq: GRCE) reported its financial results for the fiscal year ended December 31, 2025, and provided an update on its business operations. The company continues to advance its lead drug candidate, GTx-104, an intravenous formulation of nimodipine for the treatment of…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).